The EMA starts rolling review of Russian vaccine

The EMA has started reviewing the Russian Covid-19 vaccine Sputnik V. This will ensure faster approval, if the Russians file for EU approval for the vaccine.


Some obstacles may have been removed on the Russian Covid-19 vaccine's path to the EU.

On Thursday, the European Medicines Agency (EMA) announced that it has launched a so-called rolling review of the vaccine known as Sputnik V.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Further reading

Related articles

Latest news

See all jobs